New PLAVIX(R) (clopidogrel) 300mg Loading Dose Tablet Now Available For Use In ACS (acute Coronary Syndrome) Patients
Jun 30th 2008Drug InformationCardiovascular
Sanofi-aventis and Bristol-Myers Squibb announced the launch of a new 300mg tablet of the antiplatelet PLAVIX® (clopidogrel), as approved by the European Medicines Evaluation Agency (EMEA) for the treatment of appropriate ACS patients (Unstable Angina, Non-STEMI* and STEMIā? patients’ up to and including 75 years of age eligible for thrombolytic therapy) in the UK.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
